KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Other Operating Expenses (2017 - 2025)

Historic Other Operating Expenses for Elanco Animal Health (ELAN) over the last 9 years, with Q2 2025 value amounting to -$11.0 million.

  • Elanco Animal Health's Other Operating Expenses fell 45000.0% to -$11.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year decrease of 10415.16%. This contributed to the annual value of $640.0 million for FY2024, which is 95333.33% up from last year.
  • Elanco Animal Health's Other Operating Expenses amounted to -$11.0 million in Q2 2025, which was down 45000.0% from -$12.0 million recorded in Q1 2025.
  • Elanco Animal Health's Other Operating Expenses' 5-year high stood at $776.0 million during Q1 2021, with a 5-year trough of -$75.0 million in Q4 2023.
  • In the last 5 years, Elanco Animal Health's Other Operating Expenses had a median value of $667.5 million in 2022 and averaged $471.4 million.
  • As far as peak fluctuations go, Elanco Animal Health's Other Operating Expenses surged by 12701.86% in 2021, and later plummeted by 45000.0% in 2025.
  • Quarter analysis of 5 years shows Elanco Animal Health's Other Operating Expenses stood at $702.0 million in 2021, then dropped by 4.99% to $667.0 million in 2022, then plummeted by 111.24% to -$75.0 million in 2023, then skyrocketed by 953.33% to $640.0 million in 2024, then crashed by 101.72% to -$11.0 million in 2025.
  • Its last three reported values are -$11.0 million in Q2 2025, -$12.0 million for Q1 2025, and $640.0 million during Q3 2024.